Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

PRACTICE MANAGEMENT CORNER

As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More

ADVOCACY UPDATES

Costs are going up. How can I maintain my service lines without going into debt?

Question: Costs are going up. Everything seems to be 20+% more expensive. How can I maintain my service…

Read more

“If It Is Not Documented”

As featured pre-work for our 2024 Annual Meeting, Teresa Thompson and Robert Puchalski, MD, FAAOA…

Read more

Penicillin Allergy Verification and Evaluation (PAVE) Act

Penicillin Allergy Verification and Evaluation (PAVE) Act to be introduced by Rep. Bucshon. AAOA is one…

Read more

Upcoming Dates

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

04/01/25: Fellow Exam Application Deadline
Learn more

06/01/25: Research Grant Cycle
Learn more

EDUCATION

AAOA Annual Meeting

Register for FREE* to attend the 2024 AAOA Annual Meeting in-person, in Las Vegas, or virtually!

*The 2024 AAOA Annual Meeting is FREE to all AAOA members in good standing

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register 

Coming Soon! New Explorers Course — Hybrid
90-days Access Feb 27 – May 27, 2025 
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register

2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Available Now!

News and Updates

Financial Literacy in ENT: Diversifying Your Learnings & Earnings

via BackTable ENT Podcasts Surgeons are fortunate that their work is both fulfilling and well…

Read more

Apply For AAOAF Research Grants

The AAOA Foundation (AAOAF) invites applications for research grants from residents and medical students. Selected…

Read more

CEO Update, October 2024 – “October Theory”

Have you heard of the “October Theory”? Apparently, Autumn brings more than falling leaves, pumpkins,…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Congress and Administration Take Aggressive Action to Address COVID-19 Pandemic but Providers Continue to Struggle

Congress has passed four pieces of legislation and the Centers for Medicare & Medicaid Services (CMS) has released two interim final rules with comment periods (IFC) to address the increasing demands placed on the health care system by the COVID-19 pandemic. These policies have authorized new programs, appropriated trillions in new funds, and provided new regulatory flexibilities. However, many providers have
not yet received the relief needed to support their practices during this public health emergency (PHE).

Congress approved the CARES Act at the end of March. This legislation authorized the Public Health and Social Services Emergency (PHSSE) Fund to provide financial support to hospitals and other health care providers and the Paycheck Protection Program (PPP), a forgivable loan program
administered by the Small Business Administration, designed to provide support for payroll and other operating expenses, like insurance premiums, mortgage, rent, and utility payments.

Many AAOA members are eligible for funds through both these programs. The CARES Act also authorized the Treasury Department to provide financing to banks and other lenders to make direct loans to businesses with between 500-10,000 employees, expanded CMS’ telehealth authorities, provided Medicare sequester relief, and expanded coverage for COVID-19 diagnostic tests.

To provide additional funds to a number of the programs in the CARES Act, Congress passed an interim COVID-19 emergency relief package at the end of April that included an additional $75 billion for the PHSSE Fund to provide hospitals and health care providers with financial support for COVID-19 related expenses and lost revenue as well as provide funding
for targeted COVID-19 testing and care in rural areas and for the uninsured. Despite the $175 billion that has been appropriated for this fund, there are still significant concerns that the money has not supported many of the practices and providers with significant need. The Department of Health and Human Services continues to disburse these funds and details on how can be found here. This bill also included an infusion of funds for the PPP that had already exhausted its original appropriation.

Now, Congress has shifted its focus to the development of a fourth COVID-19 relief package – likely to be the last large relief package. Details on the timing and the content of this package remain unclear, however House Speaker Nancy Pelosi (D-CA) has signaled that she plans to address hazard
pay for health care workers on the front lines, funding for state and local governments, disparities in COVID-19 testing, and policies to prepare the health care system for a second surge of infections in this package. We may even see a draft of the Speaker’s legislative proposal as soon as later this week with the goal that the House will vote before Memorial Day, jumpstarting negotiations with the Senate and the White House. Ultimately, we do not expect additional legislation to be enacted before early to mid-June.

Congress and Administration Take Aggressive Action to Address COVID-19 Pandemic but Providers Continue to Struggle Using new authorities provided by Congress as well as its waiver authority during the PHE, CMS has released two interim final rules with comment period, the first on March 30 and the second on April 30, and a number of waiver. Here are
the changes that have been implemented that have a direct impact on AAOA members and their practices:

  • Congress has vastly expanded CMS’ telehealth authorities. Providers can now bill the new and established outpatient E/M services via telehealth, which requires both an audio and visual connection, to patients in their homes. E/M services delivered via telehealth services are reimbursed at the facility rate. The Office of Civil Rights has also provided HIPAA flexibilities allowing providers to serve patients using apps like FaceTime and Skype.
  • More services can now be delivered via telehealth and CMS has relaxed the process for adding new services to its telehealth services list during the PHE. The current list is available here.
  • CMS responded to provider concerns about the values of the telephone E/M services (CPT codes 99441-99443) since they have been unable to established audio and visual connections with many Medicare beneficiaries. These three codes, which prior to the PHE were not billable, have been crosswalked to CPT codes 99212, 99213, and 99214 for outpatient E/M services. The values of these codes which were increased in the second IFC are retroactive to March 1.
  • The agency has relaxed its direct supervision requirements. Now, physicians or other practitioners can provide direct supervision by using real time audio/visual technology.
  • CMS has temporarily waived Medicare and Medicaid’s requirements that physicians and non-physician practitioners must be licensed in the state where they are providing services, allowing physicians to deliver care to beneficiaries across state lines. However, state laws still apply.
  • Many providers have expressed concerns about completing the Quality Payment Program requirements during the PHE. In the Merit-based Incentive Payment System (MIPS), CMS will not impose a penalty on providers who did not submit their 2019 performance data by April 30, 2020. The agency has also modified its extreme and uncontrollable circumstances policy for those providers who have been impacted by the COVID-19 outbreak.
  • CMS has also delayed the implementation of the Qualified Clinical Data Registry (QCDR) measures testing and data collection policies by one year. These policies were originally scheduled to be implement in 2020.

CMS continues to engage with stakeholders and receive feedback on how their policies can be further adjusted to provide additional flexibilities during the PHE. AAOA will continue to keep you updated on any changes made by the agency.

Back To Top